Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Buchanan

Showing results (251-260 of 303) with videos related to

Pageof 31
Sort By:
Oral Oncology|June 7, 2005
Re: Eisen, D & Frist, S--letterS R Porter, T W J Poate, T A Hodgson, et al.
Oral Oncology|August 4, 2004
An audit of the efficacy of the oral brush biopsy technique in a specialist Oral Medicine unitT W J Poate, J A G Buchanan, T A Hodgson, et al.
Cancer Research|November 21, 2000
Breast cancer susceptibility gene 1 (BRCAI) is a coactivator of the androgen receptorJ J Park, R A Irvine, G Buchanan, et al.
AIDS (London, England)|July 21, 2017
Subclinical herpesvirus shedding among HIV-1-infected men on antiretroviral therapyArcadio Agudelo-Hernandez, Yue Chen, Arlene Bullotta, et al.
Cancer Research|July 21, 2010
MET kinase inhibitor SGX523 synergizes with epidermal growth factor receptor inhibitor erlotinib in a hepatocyte growth factor-dependent fashion to suppress carcinoma growthYu-Wen Zhang, Ben Staal, Curt Essenburg, et al.
JAMA|September 21, 1979
Antimicrobial selection by a computer. A blinded evaluation by infectious diseases expertsV L Yu, L M Fagan, S M Wraith, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 11, 2006
Probing a protein-protein interaction by in vitro evolutionGeorge Thom, Alexis C Cockroft, Andrew G Buchanan, et al.
Bioorganic & Medicinal Chemistry Letters|January 14, 2020
Corrigendum to "Investigation of biaryl heterocycles as inhibitors of Wee1 kinase" [Bioorg. Med. Chem. Lett. 29 (2019) 1481-1486]Anthony Mastracchio, Chunqiu Lai, Maricel Torrent, et al.
Journal of the American Medical Informatics Association : JAMIA|January 1, 1994
Designing medical informatics research and library--resource projects to increase what is learnedW W Stead, R B Haynes, S Fuller, et al.
Molecular Cancer Therapeutics|August 15, 2014
The CDK4/6 inhibitor LY2835219 overcomes vemurafenib resistance resulting from MAPK reactivation and cyclin D1 upregulationVipin Yadav, Teresa F Burke, Lysiane Huber, et al.
Pageof 31

Showing results (251-260 of 303) with videos related to

Sort By:
Pageof 31
Oral Oncology|June 7, 2005
Re: Eisen, D & Frist, S--letterS R Porter, T W J Poate, T A Hodgson, et al.
Oral Oncology|August 4, 2004
An audit of the efficacy of the oral brush biopsy technique in a specialist Oral Medicine unitT W J Poate, J A G Buchanan, T A Hodgson, et al.
Cancer Research|November 21, 2000
Breast cancer susceptibility gene 1 (BRCAI) is a coactivator of the androgen receptorJ J Park, R A Irvine, G Buchanan, et al.
AIDS (London, England)|July 21, 2017
Subclinical herpesvirus shedding among HIV-1-infected men on antiretroviral therapyArcadio Agudelo-Hernandez, Yue Chen, Arlene Bullotta, et al.
Cancer Research|July 21, 2010
MET kinase inhibitor SGX523 synergizes with epidermal growth factor receptor inhibitor erlotinib in a hepatocyte growth factor-dependent fashion to suppress carcinoma growthYu-Wen Zhang, Ben Staal, Curt Essenburg, et al.
JAMA|September 21, 1979
Antimicrobial selection by a computer. A blinded evaluation by infectious diseases expertsV L Yu, L M Fagan, S M Wraith, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 11, 2006
Probing a protein-protein interaction by in vitro evolutionGeorge Thom, Alexis C Cockroft, Andrew G Buchanan, et al.
Bioorganic & Medicinal Chemistry Letters|January 14, 2020
Corrigendum to "Investigation of biaryl heterocycles as inhibitors of Wee1 kinase" [Bioorg. Med. Chem. Lett. 29 (2019) 1481-1486]Anthony Mastracchio, Chunqiu Lai, Maricel Torrent, et al.
Journal of the American Medical Informatics Association : JAMIA|January 1, 1994
Designing medical informatics research and library--resource projects to increase what is learnedW W Stead, R B Haynes, S Fuller, et al.
Molecular Cancer Therapeutics|August 15, 2014
The CDK4/6 inhibitor LY2835219 overcomes vemurafenib resistance resulting from MAPK reactivation and cyclin D1 upregulationVipin Yadav, Teresa F Burke, Lysiane Huber, et al.
Pageof 31